Author Archive | Rod Raynovich

Raygent Biopharmaceutical Stock Portfolio beats the market for 2008

My biotech picks were published in Genetic Engineering News (GEN) in February 2008. My strategy was to allocate 25% in one ETF (XBI), 50% in large caps and 25% in smaller cap biotechs. My proprietary system is based on technicals, core technology and company financials. Despite all the volatility in 2008 with declines of 34-40% for […]

Continue Reading 0